Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

VitaNova Life Sciences (YJGJ) FCF Margin (2017 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed FCF Margin for 6 consecutive years, with 49.79% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin rose 4679.0% year-over-year to 49.79%, compared with a TTM value of 41.7% through Oct 2025, up 12787.0%, and an annual FY2025 reading of 7.24%, up 7311.0% over the prior year.
  • FCF Margin was 49.79% for Q4 2025 at VitaNova Life Sciences, down from 253.91% in the prior quarter.
  • Across five years, FCF Margin topped out at 253.91% in Q3 2025 and bottomed at 576.85% in Q1 2024.
  • Average FCF Margin over 5 years is 60.47%, with a median of 17.47% recorded in 2022.
  • The sharpest move saw FCF Margin plummeted -29924bps in 2023, then surged 71853bps in 2025.
  • Year by year, FCF Margin stood at 43.54% in 2021, then increased by 22bps to 53.06% in 2022, then crashed by -244bps to 76.17% in 2023, then skyrocketed by 104bps to 3.0% in 2024, then surged by 1560bps to 49.79% in 2025.
  • Business Quant data shows FCF Margin for YJGJ at 49.79% in Q4 2025, 253.91% in Q3 2025, and 24.53% in Q2 2025.